Down-regulation of miR-214 reverses erlotinib resistance in non-small-cell lung cancer through up-regulating LHX6 expression
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Down-regulation of miR-214 reverses erlotinib resistance in non-small-cell lung cancer through up-regulating LHX6 expression
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-04-05
DOI
10.1038/s41598-017-00901-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Drug Resistance to EGFR Inhibitors in Lung Cancer
- (2016) Osamu Tetsu et al. CHEMOTHERAPY
- The emergence of T790M mutation in EGFR-mutant lung adenocarcinoma patients having a history of acquired resistance to EGFR-TKI: focus on rebiopsy timing and long-term existence of T790M
- (2016) Jeng-Sen Tseng et al. Oncotarget
- Epidermal Growth Factor Receptor–Mutant Lung Cancer
- (2015) Zofia Piotrowska et al. CANCER JOURNAL
- Emerging treatment for advanced lung cancer withEGFRmutation
- (2015) Cengiz Inal et al. EXPERT OPINION ON EMERGING DRUGS
- Lhx6 and Lhx8: cell fate regulators and beyond
- (2015) Chen Zhou et al. FASEB JOURNAL
- miR-214: a potential biomarker and therapeutic for different cancers
- (2015) Tanu Sharma et al. Future Oncology
- Lhx6andLhx8promote palate development through negative regulation of a cell cycle inhibitor gene,p57Kip2
- (2015) Jeffry M. Cesario et al. HUMAN MOLECULAR GENETICS
- miR-214 as a Key Hub that Controls Cancer Networks: Small Player, Multiple Functions
- (2015) Elisa Penna et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Treatment approaches for EGFR-inhibitor-resistant patients with non-small-cell lung cancer
- (2015) Chee-Seng Tan et al. LANCET ONCOLOGY
- MiR-214 increases the sensitivity of breast cancer cells to tamoxifen and fulvestrant through inhibition of autophagy
- (2015) Xinfeng Yu et al. Molecular Cancer
- LHX6 inhibits breast cancer cell proliferation and invasion via repression of the Wnt/β-catenin signaling pathway
- (2015) ZHUANG HU et al. Molecular Medicine Reports
- MiR-214 suppressed ovarian cancer and negatively regulated semaphorin 4D
- (2015) Yang Liu et al. TUMOR BIOLOGY
- LIM homeobox transcription factors, a novel subfamily which plays an important role in cancer (Review)
- (2014) XI WANG et al. ONCOLOGY REPORTS
- Clinicopathological Significance of MicroRNA-214 in Gastric Cancer and Its Effect on Cell Biological Behaviour
- (2014) Ya-Wen Wang et al. PLoS One
- Evolution of themiR199-214cluster and vertebrate skeletal development
- (2014) Thomas Desvignes et al. RNA Biology
- MicroRNAs in cancer: biomarkers, functions and therapy
- (2014) Josie Hayes et al. TRENDS IN MOLECULAR MEDICINE
- Friend or foe: the role of microRNA in chemotherapy resistance
- (2013) Haoran Li et al. ACTA PHARMACOLOGICA SINICA
- Association of integrin beta1 and c-MET in mediating EGFR TKI gefitinib resistance in non-small cell lung cancer
- (2013) Lixia Ju et al. Cancer Cell International
- Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung Cancers
- (2013) H. A. Yu et al. CLINICAL CANCER RESEARCH
- Prediction Value of miR-483 and miR-214 in Prognosis and Multidrug Resistance of Esophageal Squamous Cell Carcinoma
- (2013) Yi Zhou et al. Genetic Testing and Molecular Biomarkers
- Loss of an EGFR-amplified chromosome 7 as a novel mechanism of acquired resistance to EGFR-TKIs in EGFR-mutated NSCLC cells
- (2013) Koh Furugaki et al. LUNG CANCER
- MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer
- (2013) Bing Li et al. LUNG CANCER
- Alternative Signaling Pathways as Potential Therapeutic Targets for Overcoming EGFR and c-Met Inhibitor Resistance in Non-Small Cell Lung Cancer
- (2013) Jason T. Fong et al. PLoS One
- Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
- (2013) Ophir Shalem et al. SCIENCE
- LHX6 acts as a novel potential tumour suppressor with epigenetic inactivation in lung cancer
- (2013) W-b Liu et al. Cell Death & Disease
- MicroRNA-214 Regulates the Acquired Resistance to Gefitinib via the PTEN/AKT Pathway in EGFR-mutant Cell Lines
- (2012) Yong-Sheng Wang et al. Asian Pacific Journal of Cancer Prevention
- Acquired resistance mechanisms to tyrosine kinase inhibitors in lung cancer with activating epidermal growth factor receptor mutation—diversity, ductility, and destiny
- (2012) Kenichi Suda et al. CANCER AND METASTASIS REVIEWS
- MicroRNA and cancer
- (2012) Martin D. Jansson et al. Molecular Oncology
- MiR-214 Targets β-Catenin Pathway to Suppress Invasion, Stem-Like Traits and Recurrence of Human Hepatocellular Carcinoma
- (2012) Hongping Xia et al. PLoS One
- EGFR Mutations and Lung Cancer
- (2011) Gilda da Cunha Santos et al. Annual Review of Pathology-Mechanisms of Disease
- A Novel ALK Secondary Mutation and EGFR Signaling Cause Resistance to ALK Kinase Inhibitors
- (2011) T. Sasaki et al. CANCER RESEARCH
- Decreased microRNA-214 levels in breast cancer cells coincides with increased cell proliferation, invasion and accumulation of the Polycomb Ezh2 methyltransferase
- (2011) Assia Derfoul et al. CARCINOGENESIS
- microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C
- (2011) Elisa Penna et al. EMBO JOURNAL
- Non-small-cell lung cancer
- (2011) Peter Goldstraw et al. LANCET
- MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sézary syndrome
- (2011) M G Narducci et al. Cell Death & Disease
- Dysregulation of miR-15a and miR-214 in human pancreatic cancer
- (2010) Xing J Zhang et al. Journal of Hematology & Oncology
- MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines
- (2010) Zhi-wei Yu et al. ORAL ONCOLOGY
- MicroRNAs in Cancer
- (2009) Ramiro Garzon et al. Annual Review of Medicine
- Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancers Dependent on the Epidermal Growth Factor Receptor Pathway
- (2009) Kim-Son H. Nguyen et al. Clinical Lung Cancer
- Role of microRNA in anticancer drug resistance
- (2009) Tongsen Zheng et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNA-214 is aberrantly expressed in cervical cancers and inhibits the growth of HeLa cells
- (2009) Zuozhen Yang et al. IUBMB LIFE
- Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application
- (2009) Aimee L. Jackson et al. NATURE REVIEWS DRUG DISCOVERY
- MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN
- (2008) H. Yang et al. CANCER RESEARCH
- Lung Cancer
- (2008) Roy S. Herbst et al. NEW ENGLAND JOURNAL OF MEDICINE
- EGFR Tyrosine Kinase Inhibitors in Lung Cancer: An Evolving Story
- (2007) Lecia V. Sequist et al. Annual Review of Medicine
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search